Advancing preparations to begin manufacturing of fibroblast-based spheroids product candidate, CYWC628, for the Phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers (DFU) patients Prepa ...

Guest writer Brian Howard faced numerous difficulties after being diagnosed with MS. Even so, people can still lean on him ...

Tiziana Life Sciences is a buy due to its platform optionality and upcoming catalysts that outweigh its dilution risk and ...

A new study out of the United States could shift how multiple sclerosis (MS) is detected and treated. Researchers say they’ve ...

Amy Schumer’s family shaped her life through love, struggle, and laughter. Read on to uncover how her parents and siblings ...

Next Gen SEO & KI-Marketing Schweiz continues to strengthen its position as Switzerland’s provider of AI-driven marketing solutions, addressing the evolving digital transformation needs of businesses ...

Cycling for a Cure to End Multiple Sclerosis NEW BERN, NC / ACCESS Newswire / October 28, 2025 / This September, 1,200 cyclists and hundreds of volunteers took part in Bike MS: Historic New Bern Ride, ...

MOG-IgG positivity is rare in MS patients, complicating diagnosis and treatment, especially in Asian populations with lower ...

Specialty drugs, especially biologics, will constitute a significant portion of global drug spending by 2029, driven by cancer care costs. Autoimmune diseases and multiple sclerosis are key short-term ...

The Federal Circuit upheld a tribunal decision invalidating a Merck & Co. unit’s patent of a multiple sclerosis drug, ...

Biogen beat Wall Street estimates for third-quarter profit, helped by better-than-expected sales of some of its multiple ...

Over the course of just three days recently, five scientists affiliated with the University of California won Nobel prizes for discoveries that can help us more effectively treat conditions such ...